Literature DB >> 23746128

Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.

L Zachariadou1, A Stathi1, P T Tassios2, A Pangalis1, N J Legakis2, J Papaparaskevas2.   

Abstract

In order to investigate for possible differences between paediatric and adult invasive Streptococcus pyogenes (iGAS) infections, a total of 142 cases were identified in 17 Greek hospitals during 2003-2007, of which 96 were children and 46 adults. Bacteraemia, soft tissue infections, streptococcal toxic shock syndrome (STSS), and necrotizing fasciitis were the main clinical presentations (67·6%, 45·1%, 13·4%, and 12·0% of cases, respectively). Bacteraemia and lymphadenitis were significantly more frequent in children (P=0·019 and 0·021, respectively), whereas STSS was more frequent in adults (P=0·017). The main predisposing factors in children were varicella and streptococcal pharyngotonsillitis (25% and 19·8%, respectively), as opposed to malignancy, intravenous drug abuse and diabetes mellitus in adults (19·6%, 15·2% and 10·9%, respectively). Of the two dominant emm-types, 1 and 12 (28·2% and 8·5%, respectively), the proportion of emm-type 12 remained stable during the study period, whereas emm-type 1 rates fluctuated considerably. Strains of emm-type 1 from children were associated with erythromycin susceptibility, STSS and intensive-care-unit admission, whereas emm-type 12 isolates from adults were associated with erythromycin and clindamycin resistance. Finally, specific emm-types were detected exclusively in adults or in children. In conclusion, several clinical and epidemiological differences were detected, that could prove useful in designing age-focused strategies for prevention and treatment of iGAS infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23746128      PMCID: PMC9151163          DOI: 10.1017/S0950268813001386

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  23 in total

1.  Conversion of the CD4+ T cell profile from T(H2)-dominant type to T(H1)-dominant type after varicella-zoster virus infection in atopic dermatitis.

Authors:  T Fujimura; R Yamanashi; M Masuzawa; Y Fujita; K Katsuoka; S Nishiyama; M Mitsuyama; K Nomoto
Journal:  J Allergy Clin Immunol       Date:  1997-08       Impact factor: 10.793

2.  Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.

Authors:  A Stathi; J Papaparaskevas; L Zachariadou; A Pangalis; N J Legakis; A Tseleni-Kotsovili; P T Tassios
Journal:  Clin Microbiol Infect       Date:  2008-08       Impact factor: 8.067

3.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections.

Authors: 
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

4.  Characteristics of group A streptococcal bacteremia with comparison between children and adults.

Authors:  Y C Huang; Y C Huang; C H Chiu; L Y Chang; H S Leu; T Y Lin
Journal:  J Microbiol Immunol Infect       Date:  2001-09       Impact factor: 4.399

5.  Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.

Authors:  Susan Rogers; Robert Commons; Margaret H Danchin; Gowri Selvaraj; Loraine Kelpie; Nigel Curtis; Roy Robins-Browne; Jonathan R Carapetis
Journal:  J Infect Dis       Date:  2007-04-26       Impact factor: 5.226

6.  Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008-9.

Authors:  T L Lamagni; A Efstratiou; J Dennis; P Nair; J Kearney; R George
Journal:  Euro Surveill       Date:  2009-02-05

7.  The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.

Authors:  Rosalyn E O'Loughlin; Angela Roberson; Paul R Cieslak; Ruth Lynfield; Ken Gershman; Allen Craig; Bernadette A Albanese; Monica M Farley; Nancy L Barrett; Nancy L Spina; Bernard Beall; Lee H Harrison; Arthur Reingold; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2007-08-29       Impact factor: 9.079

8.  Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.

Authors:  R U Wahl; R Lütticken; S Stanzel; M van der Linden; R R Reinert
Journal:  Clin Microbiol Infect       Date:  2007-09-10       Impact factor: 8.067

9.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.

Authors:  J M Musser; V Kapur; J Szeto; X Pan; D S Swanson; D R Martin
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  10 in total

1.  Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.

Authors:  F Koutouzi; A Tsakris; P Chatzichristou; E Koutouzis; G L Daikos; E Kirikou; N Petropoulou; V Syriopoulou; A Michos
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  Group A streptococcal bacteremia without a source is associated with less severe disease in children.

Authors:  Stefanie Gauguet; Asim A Ahmed; Jing Zhou; Elizabeth R Pfoh; Kathryn K Ahnger-Pier; Marvin B Harper; Al Ozonoff; Michael R Wessels; Grace M Lee
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

3.  High Incidence of Invasive Group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada.

Authors:  Natalie Bocking; Cai-Lei Matsumoto; Kassandra Loewen; Sarah Teatero; Alex Marchand-Austin; Janet Gordon; Nahuel Fittipaldi; Allison McGeer
Journal:  Open Forum Infect Dis       Date:  2016-12-07       Impact factor: 3.835

4.  Prevalent emm Types among Invasive GAS in Europe and North America since Year 2000.

Authors:  Giovanni Gherardi; Luca Agostino Vitali; Roberta Creti
Journal:  Front Public Health       Date:  2018-03-09

Review 5.  Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?

Authors:  Sharvan Sehrawat; Dhaneshwar Kumar; Barry T Rouse
Journal:  Front Cell Infect Microbiol       Date:  2018-05-25       Impact factor: 5.293

6.  Barriers and facilitators and the need for a clinical guideline for microbiological diagnostic testing in the hospital: a qualitative and quantitative study.

Authors:  Saskia J Bogers; Frederike V van Daalen; Sacha D Kuil; Menno D de Jong; Suzanne E Geerlings
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-03-07       Impact factor: 3.267

7.  A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.

Authors:  Chun-Zhen Hua; Hui Yu; Hong-Mei Xu; Lin-Hai Yang; Ai-Wei Lin; Qin Lyu; Hong-Ping Lu; Zhi-Wei Xu; Wei Gao; Xue-Jun Chen; Chuan-Qing Wang; Chun-Mei Jing
Journal:  BMC Pediatr       Date:  2019-06-05       Impact factor: 2.125

8.  Morbidity and mortality in critically ill patients with invasive group A streptococcus infection: an observational study.

Authors:  Viveka Björck; Lisa I Påhlman; Mikael Bodelsson; Ann-Cathrine Petersson; Thomas Kander
Journal:  Crit Care       Date:  2020-06-06       Impact factor: 9.097

Review 9.  The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Authors:  Andrea L Herrera; Victor C Huber; Michael S Chaussee
Journal:  Front Microbiol       Date:  2016-03-21       Impact factor: 5.640

10.  Clinical and Laboratory Features of Invasive Group A Streptococcal Infections: 8 Years Experience.

Authors:  Aslıhan Şahin; Necmi Can Yüksel; Eda Karadağ Öncel; Ahu Kara Aksay; Nisel Yılmaz; Dilek Yılmaz Çiftdoğan
Journal:  Turk Arch Pediatr       Date:  2022-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.